Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Are gliomas preventable?

Victor A Levin1

  • 1Neuro-Oncology Unit 431, University of Texas, M.D. Anderson Cancer Center, Houston 77230-1402, USA.

Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|February 17, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

Advances in neuro-oncology: contributions of the Asilomar Conference on brain tumor research and therapy.

Journal of neurosurgery·2024
Same author

Radiographic Response Assessment Strategies for Early-Phase Brain Trials in Complex Tumor Types and Drug Combinations: from Digital "Flipbooks" to Control Systems Theory.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2022
Same author

Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02.

Neuro-oncology advances·2020
Same author

Effect of eflornithine on mutation frequency in temozolomide-treated U87MG cells.

Oncotarget·2020
Same author

How far will the Voyager<sup>®</sup> take us?

CNS oncology·2019
Same journal

Future Challenges of Molecular Imaging in Oncology.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same journal

Clinical Applications of Theranostics.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same journal

Internal Radiation Therapy.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same journal

The Role of Molecular Imaging in Ion Beam Therapy.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same journal

Molecular Imaging in Photon Radiotherapy.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same journal

Advancements in Intraoperative Imaging for Enhanced Surgical Precision.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
See all related articles

Preventing glioma formation and progression by understanding genetic changes could reduce brain tumor mortality. Targeting specific mutations and chromosomal alterations offers potential strategies for primary prevention and improved survival rates.

Area of Science:

  • Neuro-oncology
  • Cancer Genetics
  • Tumor Biology

Background:

  • Gliomas are primary central nervous system tumors originating from glial cells, with variable malignancy.
  • Two key prevention strategies include inhibiting initial glioma formation and preventing lower-grade tumors from advancing to higher grades.
  • Understanding the molecular drivers of glioma development and progression is crucial for effective intervention.

Purpose of the Study:

  • To explore primary prevention, chemoprevention, and screening strategies for gliomas.
  • To discuss the chromosomal, genetic, and protein alterations linked to different glioma subtypes and their progression.
  • To examine environmental, hereditary, and infectious factors influencing glioma development and malignancy.

Main Methods:

Related Experiment Videos

  • Review of known genetic and chromosomal changes in various glioma histologic types.
  • Analysis of clinical scenarios arising from specific genetic patterns and their progression.
  • Discussion of potential preventive interventions targeting gene mutations and chromosomal abnormalities.

    • Main Results:

    • Specific gene mutations and chromosomal gains/losses are associated with low-grade (WHO 2) and high-grade (WHO 3 and 4) gliomas.
    • Preventing these molecular changes could theoretically reduce the incidence of high-grade gliomas.
    • Early diagnosis and treatment of low-grade gliomas may prevent the formation of some glioblastomas (WHO 4).

    Conclusions:

    • Modulating genetic and chromosomal alterations is a promising avenue for glioma prevention and improved patient survival.
    • Targeting molecular pathways involved in glioma development and progression is essential.
    • Early detection and therapeutic intervention for low-grade gliomas are critical for preventing malignant transformation.